The Morningstar LIC monthly report provides a snapshot of ASX-listed LICs, and whether they are trading at a premium or a ...

Join Equity Market Strategist Lochlan Halloway in this week’s Market Minute, where he’s covering the first stage of Reporting ...

We raise our fair value estimate for wide-moat Cochlear by 2% with the time value of money. Shares are overvalued as the ...

Breville’s brand power continued to underpin strong growth across its main markets in Europe, North America and APAC. However, management delayed putting a number on tariff impacts until the ...

Transurban’s ( ASX: TCL) fiscal 2025 adjusted EBITDA increased 7% to $2.85 billion on solid traffic volume growth and toll ...

The creator of the 4% rule for retirement withdrawals, Bill Bengen, has written a new book outlining fresh strategies to ...

Our healthcare analyst Shane Ponraj helps me compare the moatiness and growth prospects of two sector heavyweights.

Shares fell 17% with the market questioning if CSL (ASX:CSL) can cut staff costs without slowing revenue growth further.

Over 2 million Australians now hold ETFs in their portfolio. Betashares research shows that some of the main reasons are ...

Margins improve but primary market is limited.

Homer’s quote is the embodiment of one thing that will never change - human nature. We overindulge in excess and temperance. We create problems like the global financial crisis because by nature we ...

Telstra’s ( ASX: TLS) fiscal 2025 underlying earnings before interest, taxes, depreciation and amortisation (“EBITDA”) grew ...